Login
$AXON
$307.05 +$0.61 (0.2%) After hours

$AXON 8-K SEC Filings

Filed On Filing
05 Nov 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

DB1/ 173243953.13 SKYDIO, INC. SERIES G PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES G PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of November 5, 2026, by and between Skydio, Inc., a Delaware corporation (the “Com...

05 Nov 2026 8-K: Results of Operations and Financial Condition

Today, we announce the largest single investment in Axon’s history: a $1.2 billion investment in Skydio. Skydio is one of America’s leading drone technology companies, and this investment increases our ownership stake to 37%. Axon has al...

21 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

AMENDMENT NO. 2, dated as of September 15, 2026 (this “Amendment”), among Axon Enterprise, Inc. (the “Borrower”), the Lenders party hereto and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agen...

15 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

SCOTTSDALE, Ariz., September 15, 2026 – Axon Enterprise, Inc. (Nasdaq: AXON) (“Axon”) announced today that it intends to offer, subject to market and other conditions, $1.0 billion aggregate principal amount of 0% convertible senior note...

05 Aug 2026 8-K: Results of Operations and Financial Condition

Axon delivered another record quarter, with revenue increasing 35% year over year to $904 million — our 10th consecutive quarter of revenue growth above 30%. Demand remained robust among both new and existing customers, supporting our vi...

10 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 8, 2026, Vivek Mohindra and Eiso Kant were appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately. The Board also appointed Mr. Mohindra to serve on the Audit Committee an...

01 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 28, 2026, Axon Enterprise, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (“Annual Meeting”). The total number of shares of the Company’s common stock, par value of $0.00001 per share, voted in person or by prox...

06 May 2026 8-K: Results of Operations and Financial Condition

Axon entered 2026 with strong momentum, delivering record quarterly revenue and marking our ninth consecutive quarter of 30%+ growth. This performance was driven by robust demand across our ecosystem of products, including TASER 10, Axon...

10 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 6, 2026, Matthew McBrady notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that he will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annu...

11 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the ...

24 Feb 2026 8-K: Results of Operations and Financial Condition

Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual growth above 30% as demand for our ecosystem continues to build. We delivered a ...

13 Feb 2026 8-K: Other Events

Pursuant to a notice of redemption dated December 18, 2025, in respect of the 0.50% convertible senior notes due 2027 (the “Convertible Notes”) of Axon Enterprise, Inc. (the “Company”), the Company redeemed $840,000 aggregate principal a...

18 Dec 2025 8-K: Other Events

On December 18, 2025, Axon Enterprise, Inc. (the “Company”) delivered a notice of redemption in respect of the Company’s 0.50% convertible senior notes due 2027 (the “Notes”). Pursuant to the notice of redemption, the Company has elected...

10 Dec 2025 8-K: Unregistered Sales of Equity Securities; Other Events

The information set forth under Item 8.01 below with respect to the shares of common stock to be issued pursuant to the Exchange Agreements (as defined herein) is incorporated into this Item 3.02 by reference, insofar as it relates to th...

04 Nov 2025 8-K: Results of Operations and Financial Condition

Axon delivered another record quarter, with revenue growing 31% year over year to $711 million — our seventh consecutive quarter of growth above 30% — and GAAP net loss margin of 0.3% supporting Adjusted EBITDA margin of 24.9%.

02 Sep 2025 8-K: Departure/Election of Directors or Officers; Compensation

On August 28, 2025, Todd Morgenfeld was appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately. The Board also appointed him to serve on the Audit Committee and Mergers and Acquis...

04 Aug 2025 8-K: Results of Operations and Financial Condition

Axon closed the first half of 2025 with record quarterly revenue, reflecting consistent execution and a strong foundation for long-term growth. Second quarter revenue grew 33% year over year — our sixth consecutive quarter above 30% and ...

02 Jun 2025 8-K: Submission of Matters to a Vote of Security Holders

On May 29, 2025, Axon Enterprise, Inc. (the “Company”) held its 2025 Annual Meeting of Shareholders (“Annual Meeting”). The total number of shares of the Company’s common stock, par value of $0.00001 per share, voted in person or by prox...

07 May 2025 8-K: Results of Operations and Financial Condition; Non-Reliance on Previously Issued Financial Statements

Axon delivered a strong start to 2025, achieving record quarterly revenue while maintaining healthy margins and reinforcing our foundation for long-term growth through continued product innovation and a strengthened balance sheet. First ...

11 Mar 2025 8-K: Entry into a Material Definitive Agreement; Other Events

AMENDMENT NO. 1, dated as of March 11, 2025 (this “Amendment”), among Axon Enterprise, Inc. (the “Borrower”), the Lenders party hereto, the Issuing Bank party hereto and JPMorgan Chase Bank, N.A., as administrative agent (in such capacit...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support